NCT05579444Terminated
Systems Biology of Gastrointestinal and Related Diseases
Source: ClinicalTrials.gov · Last updated 15 Dec 2023
Reason given: Lack of enrollment.
Brief summary (registry, in English)
This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 17 (actual)
- First submitted
- 10 Oct 2022
- Start date
- 11 Nov 2022
- Primary completion date
- 29 Nov 2023
- Lead sponsor
- Viome
- Diseases
- Ulcerative colitis, Crohn's disease, Obesity, Gastric and esophageal cancer, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT05579444
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Any patient 18 years old or older that schedules a visit to WAGI clinics or endoscopy center
- Able to use electronic communications
- Able to communicate in English
- Consent to participate in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Viome Life Sciences | Bothell | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.